Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $36.2450 (-1%) ($36.2450 - $36.2450) on Wed. Apr. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.81% (three month average) | RSI | 68 | Latest Price | $36.2450(-1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Weekly Trend | HALO advances 3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(40%) XBI(39%) IWO(38%) IBB(37%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -1.405% in a week (0% probabilities). VXX(-15%) UUP(-13%) VIXM(-11%) TBT(-8%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.405% (StdDev 2.81%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $36.44 | 5 Day Moving Average | $37.15(-2.44%) | 10 Day Moving Average | $37.52(-3.4%) | 20 Day Moving Average | $36.44(-0.54%) | To recent high | -32% | To recent low | 10.4% | Market Cap | $4.954b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |